| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |